The global Ketorolac Tromethamine market was valued at US$ 244 million in 2023 and is anticipated to reach US$ 332.9 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.

Ketorolac Tromethamine Market

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term treatment of moderate to severe pain. It works by reducing inflammation and pain in the body.There is a rising prevalence of pain-related conditions such as postoperative pain, musculoskeletal pain, and migraines, which drives the demand for pain medications like ketorolac tromethamine. The aging population is more prone to chronic pain, leading to a greater need for effective pain management solutions. Ketorolac tromethamine is commonly used in geriatric patients due to its potent analgesic properties. In recent years, there has been a growing concern about the opioid epidemic and the need for non-opioid pain management options. Ketorolac tromethamine, as an NSAID, offers an alternative pain relief option with a lower risk of addiction or dependence. The global increase in surgical procedures, including both elective and emergency surgeries, drives the demand for postoperative pain management medications like ketorolac tromethamine. The development of innovative drug delivery systems, such as transdermal patches and intranasal formulations, has improved the convenience and effectiveness of ketorolac tromethamine administration, making it a preferred choice for patients. Governments worldwide are implementing regulations to promote the use of non-opioid pain medications and improve access to pain management options. These regulations create a supportive environment for the growth of the ketorolac tromethamine market.

This report aims to provide a comprehensive presentation of the global market for Ketorolac Tromethamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Tromethamine.

Report Scope

The Ketorolac Tromethamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ketorolac Tromethamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ketorolac Tromethamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ketorolac Tromethamine Market Report

Report Metric	Details
Report Name	Ketorolac Tromethamine Market
Accounted market size in 2023	US$ 244 million
Forecasted market size in 2030	US$ 332.9 million
CAGR	5.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Injection Ophthalmic Nasal Oral tablet
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy’s Laboratories, Teva, Mylan, Apotex, Sandoz, Amphastar Pharmaceuticals, Gland Pharma Limited, Akorn, Sun Pharmaceutical, Sagent Pharmaceuticals, Aurobindo Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ketorolac Tromethamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ketorolac Tromethamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ketorolac Tromethamine Market growing?

Ans: The Ketorolac Tromethamine Market witnessing a CAGR of 5.1% during the forecast period 2024-2030.

What is the Ketorolac Tromethamine Market size in 2030?

Ans: The Ketorolac Tromethamine Market size in 2030 will be US$ 332.9 million.

Who are the main players in the Ketorolac Tromethamine Market report?

Ans: The main players in the Ketorolac Tromethamine Market are Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy’s Laboratories, Teva, Mylan, Apotex, Sandoz, Amphastar Pharmaceuticals, Gland Pharma Limited, Akorn, Sun Pharmaceutical, Sagent Pharmaceuticals, Aurobindo Pharma

What are the Application segmentation covered in the Ketorolac Tromethamine Market report?

Ans: The Applications covered in the Ketorolac Tromethamine Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Ketorolac Tromethamine Market report?

Ans: The Types covered in the Ketorolac Tromethamine Market report are Injection, Ophthalmic, Nasal, Oral tablet

1 Ketorolac Tromethamine Market Overview

1.1 Product Overview and Scope of Ketorolac Tromethamine

1.2 Ketorolac Tromethamine Segment by Type

1.2.1 Global Ketorolac Tromethamine Market Value Comparison by Type (2024-2030)

1.2.2 Injection

1.2.3 Ophthalmic

1.2.4 Nasal

1.2.5 Oral tablet

1.3 Ketorolac Tromethamine Segment by Application

1.3.1 Global Ketorolac Tromethamine Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Ketorolac Tromethamine Market Size Estimates and Forecasts

1.4.1 Global Ketorolac Tromethamine Revenue 2019-2030

1.4.2 Global Ketorolac Tromethamine Sales 2019-2030

1.4.3 Global Ketorolac Tromethamine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Ketorolac Tromethamine Market Competition by Manufacturers

2.1 Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Ketorolac Tromethamine Average Price by Manufacturers (2019-2024)

2.4 Global Ketorolac Tromethamine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ketorolac Tromethamine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ketorolac Tromethamine, Product Type & Application

2.7 Ketorolac Tromethamine Market Competitive Situation and Trends

2.7.1 Ketorolac Tromethamine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ketorolac Tromethamine Players Market Share by Revenue

2.7.3 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ketorolac Tromethamine Retrospective Market Scenario by Region

3.1 Global Ketorolac Tromethamine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Ketorolac Tromethamine Global Ketorolac Tromethamine Sales by Region: 2019-2030

3.2.1 Global Ketorolac Tromethamine Sales by Region: 2019-2024

3.2.2 Global Ketorolac Tromethamine Sales by Region: 2025-2030

3.3 Global Ketorolac Tromethamine Global Ketorolac Tromethamine Revenue by Region: 2019-2030

3.3.1 Global Ketorolac Tromethamine Revenue by Region: 2019-2024

3.3.2 Global Ketorolac Tromethamine Revenue by Region: 2025-2030

3.4 North America Ketorolac Tromethamine Market Facts & Figures by Country

3.4.1 North America Ketorolac Tromethamine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Ketorolac Tromethamine Sales by Country (2019-2030)

3.4.3 North America Ketorolac Tromethamine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ketorolac Tromethamine Market Facts & Figures by Country

3.5.1 Europe Ketorolac Tromethamine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Ketorolac Tromethamine Sales by Country (2019-2030)

3.5.3 Europe Ketorolac Tromethamine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Country

3.6.1 Asia Pacific Ketorolac Tromethamine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Ketorolac Tromethamine Sales by Country (2019-2030)

3.6.3 Asia Pacific Ketorolac Tromethamine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ketorolac Tromethamine Market Facts & Figures by Country

3.7.1 Latin America Ketorolac Tromethamine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Ketorolac Tromethamine Sales by Country (2019-2030)

3.7.3 Latin America Ketorolac Tromethamine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Country

3.8.1 Middle East and Africa Ketorolac Tromethamine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Ketorolac Tromethamine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Ketorolac Tromethamine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Ketorolac Tromethamine Sales by Type (2019-2030)

4.1.1 Global Ketorolac Tromethamine Sales by Type (2019-2024)

4.1.2 Global Ketorolac Tromethamine Sales by Type (2025-2030)

4.1.3 Global Ketorolac Tromethamine Sales Market Share by Type (2019-2030)

4.2 Global Ketorolac Tromethamine Revenue by Type (2019-2030)

4.2.1 Global Ketorolac Tromethamine Revenue by Type (2019-2024)

4.2.2 Global Ketorolac Tromethamine Revenue by Type (2025-2030)

4.2.3 Global Ketorolac Tromethamine Revenue Market Share by Type (2019-2030)

4.3 Global Ketorolac Tromethamine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Ketorolac Tromethamine Sales by Application (2019-2030)

5.1.1 Global Ketorolac Tromethamine Sales by Application (2019-2024)

5.1.2 Global Ketorolac Tromethamine Sales by Application (2025-2030)

5.1.3 Global Ketorolac Tromethamine Sales Market Share by Application (2019-2030)

5.2 Global Ketorolac Tromethamine Revenue by Application (2019-2030)

5.2.1 Global Ketorolac Tromethamine Revenue by Application (2019-2024)

5.2.2 Global Ketorolac Tromethamine Revenue by Application (2025-2030)

5.2.3 Global Ketorolac Tromethamine Revenue Market Share by Application (2019-2030)

5.3 Global Ketorolac Tromethamine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Ketorolac Tromethamine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Omeros Corporation

6.2.1 Omeros Corporation Corporation Information

6.2.2 Omeros Corporation Description and Business Overview

6.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio

6.2.5 Omeros Corporation Recent Developments/Updates

6.3 Egalet US Inc.

6.3.1 Egalet US Inc. Corporation Information

6.3.2 Egalet US Inc. Description and Business Overview

6.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio

6.3.5 Egalet US Inc. Recent Developments/Updates

6.4 Allergan

6.4.1 Allergan Corporation Information

6.4.2 Allergan Description and Business Overview

6.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Allergan Ketorolac Tromethamine Product Portfolio

6.4.5 Allergan Recent Developments/Updates

6.5 Dr. Reddy’s Laboratories

6.5.1 Dr. Reddy’s Laboratories Corporation Information

6.5.2 Dr. Reddy’s Laboratories Description and Business Overview

6.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio

6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates

6.6 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teva Ketorolac Tromethamine Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Mylan

6.6.1 Mylan Corporation Information

6.6.2 Mylan Description and Business Overview

6.6.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Mylan Ketorolac Tromethamine Product Portfolio

6.7.5 Mylan Recent Developments/Updates

6.8 Apotex

6.8.1 Apotex Corporation Information

6.8.2 Apotex Description and Business Overview

6.8.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Apotex Ketorolac Tromethamine Product Portfolio

6.8.5 Apotex Recent Developments/Updates

6.9 Sandoz

6.9.1 Sandoz Corporation Information

6.9.2 Sandoz Description and Business Overview

6.9.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sandoz Ketorolac Tromethamine Product Portfolio

6.9.5 Sandoz Recent Developments/Updates

6.10 Amphastar Pharmaceuticals

6.10.1 Amphastar Pharmaceuticals Corporation Information

6.10.2 Amphastar Pharmaceuticals Description and Business Overview

6.10.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio

6.10.5 Amphastar Pharmaceuticals Recent Developments/Updates

6.11 Gland Pharma Limited

6.11.1 Gland Pharma Limited Corporation Information

6.11.2 Gland Pharma Limited Ketorolac Tromethamine Description and Business Overview

6.11.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio

6.11.5 Gland Pharma Limited Recent Developments/Updates

6.12 Akorn

6.12.1 Akorn Corporation Information

6.12.2 Akorn Ketorolac Tromethamine Description and Business Overview

6.12.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Akorn Ketorolac Tromethamine Product Portfolio

6.12.5 Akorn Recent Developments/Updates

6.13 Sun Pharmaceutical

6.13.1 Sun Pharmaceutical Corporation Information

6.13.2 Sun Pharmaceutical Ketorolac Tromethamine Description and Business Overview

6.13.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio

6.13.5 Sun Pharmaceutical Recent Developments/Updates

6.14 Sagent Pharmaceuticals

6.14.1 Sagent Pharmaceuticals Corporation Information

6.14.2 Sagent Pharmaceuticals Ketorolac Tromethamine Description and Business Overview

6.14.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio

6.14.5 Sagent Pharmaceuticals Recent Developments/Updates

6.15 Aurobindo Pharma

6.15.1 Aurobindo Pharma Corporation Information

6.15.2 Aurobindo Pharma Ketorolac Tromethamine Description and Business Overview

6.15.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio

6.15.5 Aurobindo Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ketorolac Tromethamine Industry Chain Analysis

7.2 Ketorolac Tromethamine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ketorolac Tromethamine Production Mode & Process

7.4 Ketorolac Tromethamine Sales and Marketing

7.4.1 Ketorolac Tromethamine Sales Channels

7.4.2 Ketorolac Tromethamine Distributors

7.5 Ketorolac Tromethamine Customers

8 Ketorolac Tromethamine Market Dynamics

8.1 Ketorolac Tromethamine Industry Trends

8.2 Ketorolac Tromethamine Market Drivers

8.3 Ketorolac Tromethamine Market Challenges

8.4 Ketorolac Tromethamine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Amphastar Pharmaceuticals

Gland Pharma Limited

Akorn

Sun Pharmaceutical

Sagent Pharmaceuticals

Aurobindo Pharma

List of Tables

Table 1. Global Ketorolac Tromethamine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Ketorolac Tromethamine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Ketorolac Tromethamine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Ketorolac Tromethamine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Ketorolac Tromethamine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Ketorolac Tromethamine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Ketorolac Tromethamine Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Ketorolac Tromethamine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ketorolac Tromethamine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ketorolac Tromethamine, Product Type & Application

Table 12. Global Key Manufacturers of Ketorolac Tromethamine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Ketorolac Tromethamine Sales by Region (2019-2024) & (K Units)

Table 18. Global Ketorolac Tromethamine Sales Market Share by Region (2019-2024)

Table 19. Global Ketorolac Tromethamine Sales by Region (2025-2030) & (K Units)

Table 20. Global Ketorolac Tromethamine Sales Market Share by Region (2025-2030)

Table 21. Global Ketorolac Tromethamine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Ketorolac Tromethamine Revenue Market Share by Region (2019-2024)

Table 23. Global Ketorolac Tromethamine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Ketorolac Tromethamine Revenue Market Share by Region (2025-2030)

Table 25. North America Ketorolac Tromethamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Ketorolac Tromethamine Sales by Country (2019-2024) & (K Units)

Table 27. North America Ketorolac Tromethamine Sales by Country (2025-2030) & (K Units)

Table 28. North America Ketorolac Tromethamine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Ketorolac Tromethamine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Ketorolac Tromethamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Ketorolac Tromethamine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Ketorolac Tromethamine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Ketorolac Tromethamine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Ketorolac Tromethamine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Ketorolac Tromethamine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Ketorolac Tromethamine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Ketorolac Tromethamine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Ketorolac Tromethamine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Ketorolac Tromethamine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Ketorolac Tromethamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Ketorolac Tromethamine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Ketorolac Tromethamine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Ketorolac Tromethamine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Ketorolac Tromethamine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Ketorolac Tromethamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Ketorolac Tromethamine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Ketorolac Tromethamine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Ketorolac Tromethamine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Ketorolac Tromethamine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Ketorolac Tromethamine Sales (K Units) by Type (2019-2024)

Table 51. Global Ketorolac Tromethamine Sales (K Units) by Type (2025-2030)

Table 52. Global Ketorolac Tromethamine Sales Market Share by Type (2019-2024)

Table 53. Global Ketorolac Tromethamine Sales Market Share by Type (2025-2030)

Table 54. Global Ketorolac Tromethamine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Ketorolac Tromethamine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Ketorolac Tromethamine Revenue Market Share by Type (2019-2024)

Table 57. Global Ketorolac Tromethamine Revenue Market Share by Type (2025-2030)

Table 58. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2019-2024)

Table 59. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2025-2030)

Table 60. Global Ketorolac Tromethamine Sales (K Units) by Application (2019-2024)

Table 61. Global Ketorolac Tromethamine Sales (K Units) by Application (2025-2030)

Table 62. Global Ketorolac Tromethamine Sales Market Share by Application (2019-2024)

Table 63. Global Ketorolac Tromethamine Sales Market Share by Application (2025-2030)

Table 64. Global Ketorolac Tromethamine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Ketorolac Tromethamine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Ketorolac Tromethamine Revenue Market Share by Application (2019-2024)

Table 67. Global Ketorolac Tromethamine Revenue Market Share by Application (2025-2030)

Table 68. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2019-2024)

Table 69. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2025-2030)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Ketorolac Tromethamine Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Omeros Corporation Corporation Information

Table 76. Omeros Corporation Description and Business Overview

Table 77. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Omeros Corporation Ketorolac Tromethamine Product

Table 79. Omeros Corporation Recent Developments/Updates

Table 80. Egalet US Inc. Corporation Information

Table 81. Egalet US Inc. Description and Business Overview

Table 82. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Egalet US Inc. Ketorolac Tromethamine Product

Table 84. Egalet US Inc. Recent Developments/Updates

Table 85. Allergan Corporation Information

Table 86. Allergan Description and Business Overview

Table 87. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Allergan Ketorolac Tromethamine Product

Table 89. Allergan Recent Developments/Updates

Table 90. Dr. Reddy’s Laboratories Corporation Information

Table 91. Dr. Reddy’s Laboratories Description and Business Overview

Table 92. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product

Table 94. Dr. Reddy’s Laboratories Recent Developments/Updates

Table 95. Teva Corporation Information

Table 96. Teva Description and Business Overview

Table 97. Teva Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Teva Ketorolac Tromethamine Product

Table 99. Teva Recent Developments/Updates

Table 100. Mylan Corporation Information

Table 101. Mylan Description and Business Overview

Table 102. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Mylan Ketorolac Tromethamine Product

Table 104. Mylan Recent Developments/Updates

Table 105. Apotex Corporation Information

Table 106. Apotex Description and Business Overview

Table 107. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Apotex Ketorolac Tromethamine Product

Table 109. Apotex Recent Developments/Updates

Table 110. Sandoz Corporation Information

Table 111. Sandoz Description and Business Overview

Table 112. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Sandoz Ketorolac Tromethamine Product

Table 114. Sandoz Recent Developments/Updates

Table 115. Amphastar Pharmaceuticals Corporation Information

Table 116. Amphastar Pharmaceuticals Description and Business Overview

Table 117. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Amphastar Pharmaceuticals Ketorolac Tromethamine Product

Table 119. Amphastar Pharmaceuticals Recent Developments/Updates

Table 120. Gland Pharma Limited Corporation Information

Table 121. Gland Pharma Limited Description and Business Overview

Table 122. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Gland Pharma Limited Ketorolac Tromethamine Product

Table 124. Gland Pharma Limited Recent Developments/Updates

Table 125. Akorn Corporation Information

Table 126. Akorn Description and Business Overview

Table 127. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Akorn Ketorolac Tromethamine Product

Table 129. Akorn Recent Developments/Updates

Table 130. Sun Pharmaceutical Corporation Information

Table 131. Sun Pharmaceutical Description and Business Overview

Table 132. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Sun Pharmaceutical Ketorolac Tromethamine Product

Table 134. Sun Pharmaceutical Recent Developments/Updates

Table 135. Sagent Pharmaceuticals Corporation Information

Table 136. Sagent Pharmaceuticals Description and Business Overview

Table 137. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Sagent Pharmaceuticals Ketorolac Tromethamine Product

Table 139. Sagent Pharmaceuticals Recent Developments/Updates

Table 140. Aurobindo Pharma Corporation Information

Table 141. Aurobindo Pharma Description and Business Overview

Table 142. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. Aurobindo Pharma Ketorolac Tromethamine Product

Table 144. Aurobindo Pharma Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Ketorolac Tromethamine Distributors List

Table 148. Ketorolac Tromethamine Customers List

Table 149. Ketorolac Tromethamine Market Trends

Table 150. Ketorolac Tromethamine Market Drivers

Table 151. Ketorolac Tromethamine Market Challenges

Table 152. Ketorolac Tromethamine Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Ketorolac Tromethamine

Figure 2. Global Ketorolac Tromethamine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Ketorolac Tromethamine Market Share by Type in 2023 & 2030

Figure 4. Injection Product Picture

Figure 5. Ophthalmic Product Picture

Figure 6. Nasal Product Picture

Figure 7. Oral tablet Product Picture

Figure 8. Global Ketorolac Tromethamine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Ketorolac Tromethamine Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Others

Figure 13. Global Ketorolac Tromethamine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Ketorolac Tromethamine Market Size (2019-2030) & (US$ Million)

Figure 15. Global Ketorolac Tromethamine Sales (2019-2030) & (K Units)

Figure 16. Global Ketorolac Tromethamine Average Price (USD/Unit) & (2019-2030)

Figure 17. Ketorolac Tromethamine Report Years Considered

Figure 18. Ketorolac Tromethamine Sales Share by Manufacturers in 2023

Figure 19. Global Ketorolac Tromethamine Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Ketorolac Tromethamine Players: Market Share by Revenue in 2023

Figure 21. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Ketorolac Tromethamine Sales Market Share by Country (2019-2030)

Figure 24. North America Ketorolac Tromethamine Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Ketorolac Tromethamine Sales Market Share by Country (2019-2030)

Figure 28. Europe Ketorolac Tromethamine Revenue Market Share by Country (2019-2030)

Figure 29. Germany Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region (2019-2030)

Figure 36. China Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Ketorolac Tromethamine Sales Market Share by Country (2019-2030)

Figure 47. Latin America Ketorolac Tromethamine Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Ketorolac Tromethamine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Ketorolac Tromethamine by Type (2019-2030)

Figure 57. Global Revenue Market Share of Ketorolac Tromethamine by Type (2019-2030)

Figure 58. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Ketorolac Tromethamine by Application (2019-2030)

Figure 60. Global Revenue Market Share of Ketorolac Tromethamine by Application (2019-2030)

Figure 61. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2019-2030)

Figure 62. Ketorolac Tromethamine Value Chain

Figure 63. Ketorolac Tromethamine Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions